Cadence Bank Biogen Inc. Transaction History

Cadence Bank

$1.45 Billion
Q3 2024

A detailed history of Cadence Bank transactions in Biogen Inc. stock. As of the latest transaction made, Cadence Bank holds 2,351 shares of BIIB stock, worth $350,346. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,351

Previous 2,412 2.53%

Holding current value

$350,346

Previous $559,000 18.6%

% of portfolio

0.03%

Previous 0.04%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$189.07 - $236.8 $11,533 - $14,444	-61 Reduced 2.53%	2,351 $455,000
Q2 2024 Aug 13, 2024	SELL	$190.52 - $236.72 $3,619 - $4,497	-19 Reduced 0.78%	2,412 $559,000
Q1 2024 May 14, 2024	BUY	$212.02 - $267.71 $2,968 - $3,747	14 Added 0.58%	2,431 $524,000
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $9,633 - $11,132	35 Added 1.47%	2,417 $688,000
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $6,927 - $7,893	-27 Reduced 1.12%	2,382 $662,000
Q4 2022 Feb 13, 2023	SELL	$252.44 - $306.72 $8,078 - $9,815	-32 Reduced 1.31%	2,409 $667,000
Q3 2022 Nov 10, 2022	BUY	$194.69 - $268.46 $20,831 - $28,725	107 Added 4.58%	2,441 $652,000
Q2 2022 Aug 12, 2022	SELL	$187.54 - $223.02 $14,440 - $17,172	-77 Reduced 3.19%	2,334 $476,000
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $17,051 - $21,484	-88 Reduced 3.52%	2,411 $507,000
Q4 2021 Feb 11, 2022	BUY	$223.92 - $287.77 $1,343 - $1,726	6 Added 0.24%	2,499 $600,000
Q3 2021 Nov 10, 2021	BUY	$282.99 - $369.05 $50,655 - $66,059	179 Added 7.74%	2,493 $705,000
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $12,173 - $19,491	47 Added 2.07%	2,314 $802,000
Q1 2021 May 11, 2021	BUY	$242.95 - $284.63 $11,175 - $13,092	46 Added 2.07%	2,267 $634,000
Q4 2020 Feb 04, 2021	SELL	$236.26 - $355.63 $42,290 - $63,657	-179 Reduced 7.46%	2,221 $543,000
Q3 2020 Nov 09, 2020	SELL	$264.77 - $305.71 $36,803 - $42,493	-139 Reduced 5.47%	2,400 $681,000
Q2 2020 Jul 27, 2020	SELL	$258.66 - $342.55 $3,362 - $4,453	-13 Reduced 0.51%	2,539 $680,000
Q1 2020 Apr 30, 2020	BUY	$268.85 - $341.04 $19,894 - $25,236	74 Added 2.99%	2,552 $808,000
Q4 2019 Feb 04, 2020	BUY	$220.06 - $304.07 $660 - $912	3 Added 0.12%	2,478 $735,000
Q3 2019 Nov 06, 2019	SELL	$217.44 - $243.88 $2,826 - $3,170	-13 Reduced 0.52%	2,475 $577,000
Q2 2019 Jul 30, 2019	BUY	$219.29 - $241.72 $11,183 - $12,327	51 Added 2.09%	2,488 $582,000
Q1 2019 May 02, 2019	BUY	$216.71 - $338.96 $18,853 - $29,489	87 Added 3.7%	2,437 $576,000
Q4 2018 Feb 07, 2019	BUY	$278.5 - $352.75 $15,317 - $19,401	55 Added 2.4%	2,350 $707,000
Q3 2018 Oct 25, 2018	SELL	$293.51 - $383.83 $22,600 - $29,554	-77 Reduced 3.25%	2,295 $811,000
Q2 2018 Aug 09, 2018	BUY	$257.52 - $306.91 $51,504 - $61,382	200 Added 9.21%	2,372 $688,000
Q1 2018 May 03, 2018	BUY	$260.13 - $367.91 $48,124 - $68,063	185 Added 9.31%	2,172 $595,000
Q4 2017 Feb 12, 2018	BUY	$307.64 - $344.58 $611,280 - $684,680	1,987	1,987 $0

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cadence Bank, based on Form 13F filings with the SEC.

News

Stay updated on Cadence Bank with notifications on news.

Account